Researchers report case of bone marrow transplant patient off ART for 288 days without HIV rebound
New HIV capsid inhibitors show high potency and prolonged activity in early studies
HIV’s milder cousin may be less mild than previously thought
Integrase inhibitors may increase risk of IRIS in late presenters for HIV treatment
What is safe sex now? Does it include undetectable viral load and PrEP?
Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?
Bacterial vaginosis does not affect efficacy of oral PrEP in women
NAM's director talks about PrEP and the decline in HIV diagnoses on BBC2's Newsnight
Monoclonal antibodies show promise for HIV-positive people with limited treatment options
